Novel strategy for identification of candidate cytotoxic T-cell epitopes from human preproinsulin

被引:18
作者
Chang, L
Kjer-Nielsen, L
Flynn, S
Brooks, AG
Mannering, SI
Honeyman, MC
Harrison, LC
McCluskey, J [1 ]
Purcell, AW
机构
[1] Univ Melbourne, Dept Microbiol & Immunol & ImmunoID, Parkville, Vic 3010, Australia
[2] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Parkville, Vic 3050, Australia
来源
TISSUE ANTIGENS | 2003年 / 62卷 / 05期
关键词
HLA-binding studies; mass spectrometry; preproinsulin; T-cell epitope;
D O I
10.1034/j.1399-0039.2003.00122.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We describe a strategy for identifying ligands of human leukocyte antigen (HLA) class I molecules based on a peptide library-mediated in vitro assembly of recombinant class I molecules. We established a microscale class I assembly assay and used a capture ELISA to quantify the assembled HLA-peptide complexes. The identity of the bound ligands was then deduced by mass spectrometry. In this method, HLA complexes assembled in vitro in the presence of components of a mixture of peptides were immunoprecipitated and the bound peptide(s) identified by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry. This process of epitope extraction is robust and can be used with complex mixtures containing in excess of 300 candidate ligands. A library of overlapping peptides representing all potential octamers, nonamers and decamers from human preproinsulin was synthesized using unique library chemistry. Peptides from the library were used to initiate assembly of recombinant HLA-B8, HLA-B15 and HLA-A2, facilitating the identification of candidate T-cell epitopes from preproinsulin.
引用
收藏
页码:408 / 417
页数:10
相关论文
共 45 条
[1]   Poor correspondence between predicted and experimental binding of peptides to class I MHC molecules [J].
Andersen, MH ;
Tan, L ;
Sondergaard, I ;
Zeuthen, J ;
Elliott, T ;
Haurum, JS .
TISSUE ANTIGENS, 2000, 55 (06) :519-531
[2]   Crystal structure of a non-canonical low-affinity peptide complexed with MHC class I: A new approach for vaccine design [J].
Apostolopoulos, V ;
Yu, MM ;
Corper, AL ;
Teyton, L ;
Pietersz, GA ;
McKenzie, IFC ;
Wilson, IA .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 318 (05) :1293-1305
[3]   Crystal structure of a non-canonical high affinity peptide complexed with MHC class I: A novel use of alternative anchors [J].
Apostolopoulos, V ;
Yu, MM ;
Corper, AL ;
Li, WJ ;
McKenzie, IFC ;
Teyton, L ;
Wilson, IA .
JOURNAL OF MOLECULAR BIOLOGY, 2002, 318 (05) :1307-1316
[4]  
Bilsborough J, 1999, J IMMUNOL, V162, P3534
[5]   Electrospray mass spectrometry for the identification of MHC class I-associated peptides expressed on cancer cells [J].
Bonner, PLR ;
Lill, JR ;
Hill, S ;
Creaser, CS ;
Rees, RC .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 262 (1-2) :5-19
[6]  
Butz EA, 1998, J IMMUNOL, V160, P2139
[7]   Description and prediction of peptide-MHC binding: the 'human MHC project' [J].
Buus, S .
CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (02) :209-213
[8]   IDENTIFICATION OF MULTIRESTRICTED IMMUNODOMINANT REGIONS RECOGNIZED BY CYTOLYTIC T-LYMPHOCYTES IN THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN [J].
CULMANNPENCIOLELLI, B ;
LAMHAMEDICHERRADI, S ;
COUILLIN, I ;
GUEGAN, N ;
LEVY, JP ;
GUILLET, JG ;
GOMARD, E .
JOURNAL OF VIROLOGY, 1994, 68 (11) :7336-7343
[9]  
DIBRINO M, 1994, J IMMUNOL, V152, P620
[10]   Reversal of immunodominance among antoantigenic T-cell epitopes [J].
Fairchild, PJ .
AUTOIMMUNITY, 1999, 30 (04) :209-221